Therapeutic ultrasound segment is expected to grow at a fast pace over the forecast period
According to The Insight Partners market research study titled ‘High-Intensity Focused Ultrasound Therapy to 2027 – Global Analysis and Forecasts by Modality, Method, Application, and End User.’ The global high intensity focused ultrasound therapy market is expected to reach US$ 755.46 Mn in 2027 from US$ 417.98 Mn in 2018. The market is estimated to grow with a CAGR of 7.1% from 2019-2027. The report highlights the trends prevalent in the global high-intensity focused ultrasound therapy market and the factors driving the market along with those that act as deterrents to its growth.
Global high-intensity focused ultrasound therapy market, based on the modality is segmented into therapeutic ultrasound, hemostasis, and others. In 2018, the therapeutic ultrasound segment held a largest market share of the High-Intensity Focused Ultrasound therapy market. This segment is also expected to dominate the market in 2027 because it increases the healing rates, tissue relaxation, and its heating, local blood flow, and scar tissue breakdown. Moreover, others segment is expected to grow at significant rate, in the forecast period 2019 to 2027 because lithotripsy, thrombolysis, immunomodulation, and among others medical procedures are increasing.
The market for High-Intensity Focused Ultrasound therapy is expected to grow, owing to factors such as growing cancer prevalence across the globe, rising incidences of kidney stone and prostate diseases, rising preference for non-invasive procedures. In addition, growing hospital industry in developing nations are likely to have a positive impact on the growth of the market in the coming years.
The major players operating in the High-Intensity Focused Ultrasound therapy market include Image Guided Therapy, EDAP, Sonacare Medical and LLC, Koninklijke Philips N.V., Chongqing Haifu Medical Technology Co., Ltd., Shanghai A & S Science Technology Development Co.,Ltd, Mianyang Sonic Electronic, Insightec Ltd., Alpinion Medical Systems Co., Ltd., FUS Instruments among others. The market has witnessed various organic as well as inorganic developments during recent years in the High-Intensity Focused Ultrasound therapy market. For instance, in July 2019, Insightec received the FDA approval to the Exablate Neuro, it has focused ultrasound device for performing incision-less thalamotomy guided by MR imaging.
Global High-Intensity Focused Ultrasound Therapy market, By Regions, 2018 (%) High Intensity Focused Ultrasound Therapy Market to 2027 - Global Analysis and Forecasts By Modality (Therapeutic Ultrasound, Hemostasis, Others); Method (Non-Invasive, Minimal-Invasive); Application (Uterine Fibroids, Prostate Cancer, Others); End User (Hospitals, Research Centers, Diagnostic Centers), and Geography
High Intensity Focused Ultrasound Therapy Market Report to 2027
Download Free Sample
The report segments the global High-Intensity Focused Ultrasound Therapy market as follows:
Global High-Intensity Focused Ultrasound Therapy market – By Modality
- Therapeutic Ultrasound
- Hemostasis
- Others
Global High-Intensity Focused Ultrasound Therapy market – By Method
- Non-Invasive
- Minimal-Invasive
Global High-Intensity Focused Ultrasound Therapy market – By Application
- Uterine Fibroids
- Prostate Cancer
- Others
Global High-Intensity Focused Ultrasound Therapy market – By End User
- Hospitals
- Research Centers
- Diagnostic Centers
Global High-Intensity Focused Ultrasound Therapy market – By Geography
- North America
- US
- Canada
- Mexico
- Europe
- France
- Germany
- U.K
- Spain
- Italy
- Asia Pacific (APAC)
-
Download Free PDF Brochure
-